PTP
BNGO icon

Platform Technology Partners’s Bionano Genomics BNGO Stock Holding History

Platform Technology Partners’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-97
Closed -$37.5K – 208
2023
Q2 		$37.5K Buy
97
+2
+2% +$903 0.02% 196
2023
Q1 		$63.5K Hold
95
– – 0.03% 190
2022
Q4 		$83.5K Buy
95
+41
+76% +$51.6K 0.04% 185
2022
Q3 		$59K Buy
54
+2
+4% +$2.64K 0.03% 178
2022
Q2 		$43K Hold
52
– – 0.02% 192
2022
Q1 		$81K Buy
52
+3
+6% +$4.05K 0.04% 196
2021
Q4 		$87K Buy
49
+20
+69% +$53.5K 0.04% 206
2021
Q3 		$95K Buy
29
+1
+4% +$3.5K 0.04% 213
2021
Q2 		$125K Buy
+28
New +$111K 0.05% 236

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Platform Technology Partners's BNGO Position: Q3 2023 in Review

Platform Technology Partners sold out of Bionano Genomics (BNGO) in Q3 2023, closing a stake of 97 shares — an estimated $37.5K sold.

Platform Technology Partners first reported a position in BNGO in Q2 2021 and held it in 9 quarters. The position peaked at $125K in Q2 2021. 46 funds tracked by Wall St. Rank hold BNGO as of Q3 2023.

  • Platform Technology Partners reported no remaining Bionano Genomics position as of Q3 2023 after selling out during the quarter.
  • Platform Technology Partners sold 97 Bionano Genomics shares in Q3 2023, an estimated $37.5K.
  • Platform Technology Partners first reported a position in Bionano Genomics in Q2 2021 and held it in 9 quarters.
  • Platform Technology Partners's Bionano Genomics position peaked at $125K in Q2 2021.
  • 46 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2023.

Based on Platform Technology Partners's 13F filing for Q3 2023, filed 8 Nov 2023.